ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
82.135
-0.18%
Bitcoin
67,842.41
-0.47%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ardelyx Inc (ARDX)

  7. Ardelyx Inc (ARDX) News

ARDX

Ardelyx (ARDX)

Ardelyx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARDX
DateTimeSourceHeadlineSymbolCompany
07/18/20248:00AMGlobeNewswire Inc.Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024NASDAQ:ARDXArdelyx Inc
07/17/20245:10PMGlobeNewswire Inc.Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful MedicinesNASDAQ:ARDXArdelyx Inc
07/02/20247:00AMGlobeNewswire Inc.To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPANASDAQ:ARDXArdelyx Inc
06/28/20248:17AMGlobeNewswire Inc.Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare DisciplinesNASDAQ:ARDXArdelyx Inc
06/17/20246:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
06/17/20246:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
06/17/20246:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
06/17/20249:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARDXArdelyx Inc
06/13/20244:12PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARDXArdelyx Inc
06/07/20246:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
06/05/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
06/05/20246:09PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARDXArdelyx Inc
06/04/20248:57AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARDXArdelyx Inc
05/30/20244:02PMGlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
05/23/20244:58PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARDXArdelyx Inc
05/23/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
05/23/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
05/23/20244:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
05/23/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
05/23/20244:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
05/23/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
05/22/20248:02AMGlobeNewswire Inc.Ardelyx to Participate at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:ARDXArdelyx Inc
05/21/20248:02AMGlobeNewswire Inc.Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in AdultsNASDAQ:ARDXArdelyx Inc
05/16/20248:01AMGlobeNewswire Inc.Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)NASDAQ:ARDXArdelyx Inc
05/14/20244:02PMGlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
05/09/20244:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
05/07/20244:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
05/07/20248:01AMGlobeNewswire Inc.Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week ConferenceNASDAQ:ARDXArdelyx Inc
05/02/20244:02PMGlobeNewswire Inc.Ardelyx Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARDXArdelyx Inc
05/01/20248:00AMGlobeNewswire Inc.Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical MeetingsNASDAQ:ARDXArdelyx Inc
 Showing the most relevant articles for your search:NASDAQ:ARDX

Your Recent History

BOV
ITSAG942
ITSAG942 Ex:9,32
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved